Palmer Adam C, Kishony Roy
Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA.
1] Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA [2] Faculty of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Nat Commun. 2014 Jul 1;5:4296. doi: 10.1038/ncomms5296.
Overexpression of a drug's molecular target often increases drug resistance, offering a pathway for adaptive evolution and a tool for target identification. It is unclear though why this phenomenon applies to some drugs but not others. Here we gradually overexpressed antibiotic targets in Escherichia coli and found that drug resistance can increase, remain unchanged, decrease or even change non-monotonically. Even a single target can produce opposing responses to its different inhibitors. We explain these contradicting effects with quantitative models of enzyme inhibition that account for fitness costs and the biochemical activity or inactivity of drug-enzyme complexes. Thus, target overexpression confers resistance or sensitivity as a predictable property of drug mechanism, explaining its variable presence in nature as a resistance mechanism. Though overexpression screens may fail at identifying unknown targets, overexpressing known or putative targets provides a systematic approach to distinguish between simple inhibition and complex mechanisms of drug action.
药物分子靶点的过表达通常会增加耐药性,这为适应性进化提供了一条途径,也是一种靶点识别工具。不过,尚不清楚为何这种现象适用于某些药物而不适用于其他药物。在这里,我们在大肠杆菌中逐步过表达抗生素靶点,发现耐药性可能增加、保持不变、降低甚至非单调变化。即使是单个靶点,对其不同抑制剂也会产生相反的反应。我们用酶抑制的定量模型来解释这些相互矛盾的效应,该模型考虑了适应性成本以及药物 - 酶复合物的生化活性或无活性。因此,靶点过表达赋予耐药性或敏感性,这是药物作用机制的一种可预测特性,解释了其作为耐药机制在自然界中存在的变异性。虽然过表达筛选可能无法识别未知靶点,但过表达已知或假定的靶点提供了一种系统方法,以区分简单抑制和复杂的药物作用机制。